NRGSX
Price
$62.80
Change
+$0.25 (+0.40%)
Updated
Oct 17 closing price
Net Assets
8.71B
WSCYX
Price
$21.25
Change
-$0.10 (-0.47%)
Updated
Oct 17 closing price
Net Assets
1.09B
Interact to see
Advertisement

NRGSX vs WSCYX

Header iconNRGSX vs WSCYX Comparison
Open Charts NRGSX vs WSCYXBanner chart's image
Neuberger Berman Genesis R6
Price$62.80
Change+$0.25 (+0.40%)
VolumeN/A
Net Assets8.71B
Macquarie Small Cap Growth Y
Price$21.25
Change-$0.10 (-0.47%)
VolumeN/A
Net Assets1.09B
NRGSX vs WSCYX Comparison Chart in %
View a ticker or compare two or three
VS
NRGSX vs. WSCYX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRGSX is a Hold and WSCYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.71B vs. WSCYX (1.09B). NRGSX pays higher dividends than WSCYX: NRGSX (0.06) vs WSCYX (0.00). NRGSX was incepted earlier than WSCYX: NRGSX (13 years) vs WSCYX (30 years). WSCYX (1.29) is less costly to investors than NRGSX (0.74). WSCYX is a more actively managed with annual turnover of: 76.00 vs. NRGSX (13.00). NRGSX (0) and WSCYX (0) have matching initial minimum investment requirements. WSCYX annual gain was more profitable for investors over the last year : 5.67 vs. NRGSX (-10.12). NRGSX return over 5 years is better than : -2.32 vs. WSCYX (-17.46).
NRGSXWSCYXNRGSX / WSCYX
Total Expense Ratio0.741.1365%
Annual Report Gross Expense Ratio0.741.2957%
Fund Existence13 years30 years-
Gain YTD-3.90210.447-37%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets8.71B1.09B797%
Annual Yield % from dividends0.060.00-
Returns for 1 year-10.125.67-178%
Returns for 3 years5.9023.2625%
Returns for 5 years-2.32-17.4613%
Returns for 10 years10.244.54226%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFNAX73.750.46
+0.63%
Janus Henderson Global Life Sciences A
GGCCX102.840.38
+0.37%
Gabelli Growth C
GMCUX16.770.04
+0.24%
Goldman Sachs Small/Mid Cap Equity R6
RLEFX38.980.04
+0.10%
American Funds American Balanced R5E
MSECX11.320.01
+0.09%
Morgan Stanley Inst International Eq C